Woodline Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Woodline Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-74,571	Closed	-$2.07M	–	1021
2025 Q3	$2.07M	Buy	+74,571	New	+$1.88M	0.01%	729
2025 Q2	–	Sell	-62,368	Closed	-$1.29M	–	923
2025 Q1	$1.29M	Sell	62,368 -16,862	-21%	-$424K	0.01%	730
2024 Q4	$1.87M	Buy	+79,230	New	+$1.95M	0.01%	663

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Woodline Partners's ARKG Position: Q4 2025 in Review

Woodline Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 74,571 shares — an estimated $2.07M sold.

Woodline Partners first reported a position in ARKG in Q4 2024 and held it in 3 quarters. The position peaked at $2.07M in Q3 2025. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

Woodline Partners reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
Woodline Partners sold 74,571 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $2.07M.
Woodline Partners first reported a position in ARK Genomic Revolution ETF in Q4 2024 and held it in 3 quarters.
Woodline Partners's ARK Genomic Revolution ETF position peaked at $2.07M in Q3 2025.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.